MEPSEVII
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 04 Nov 2024)
What this means for you
Registered since 19 Feb 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87295206
- Registration number
- 5681146
- Mark type
- Stylized text
- Filed
- 10 Jan 2017
- Published for opposition
- 28 Nov 2017
- Registered
- 19 Feb 2019
- Attorney of record
- Brian Focarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders and enzyme disorders
Owner
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
Prosecution history
- 04 Nov 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Nov 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Aug 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Aug 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Aug 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Aug 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Aug 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 May 2024 — TEAS SECTION 8 & 15 RECEIVED
- 19 Feb 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Feb 2019 — REGISTERED-PRINCIPAL REGISTER
- 18 Jan 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Jan 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Jan 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Jan 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE